LCG
BLUE

Lisanti Capital Growth’s bluebird bio BLUE Stock Holding History

Lisanti Capital Growth’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-240
Closed -$554K – 117
2017
Q4 		$554K Buy
240
+69
+40% +$140K 0.32% 103
2017
Q3 		$304K Buy
+171
New +$239K 0.19% 108
2015
Q1 		– Sell
-973
Closed -$1.16M – 93
2014
Q4 		$1.16M Sell
973
-1,688
-63% -$1.13M 0.58% 73
2014
Q3 		$1.24M Buy
+2,661
New +$1.23M 0.62% 73

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Lisanti Capital Growth's BLUE Position: Q1 2018 in Review

Lisanti Capital Growth sold out of bluebird bio (BLUE) in Q1 2018, closing a stake of 240 shares — an estimated $554K sold.

Lisanti Capital Growth first reported a position in BLUE in Q3 2014 and held it in 4 quarters. The position peaked at $1.24M in Q3 2014. 303 funds tracked by Wall St. Rank hold BLUE as of Q1 2018.

  • Lisanti Capital Growth reported no remaining bluebird bio position as of Q1 2018 after selling out during the quarter.
  • Lisanti Capital Growth sold 240 bluebird bio shares in Q1 2018, an estimated $554K.
  • Lisanti Capital Growth first reported a position in bluebird bio in Q3 2014 and held it in 4 quarters.
  • Lisanti Capital Growth's bluebird bio position peaked at $1.24M in Q3 2014.
  • 303 funds tracked by Wall St. Rank held bluebird bio as of Q1 2018.

Based on Lisanti Capital Growth's 13F filing for Q1 2018, filed 15 May 2018.